Home | My Profile | Contact Us
Research Trends Products  |   order gateway  |   author gateway  |   editor gateway  
Register | Forgot Password

Author Resources
 Author Gateway
 Article submission guidelines

Editor Resources
 Editor/Referee Gateway

 Regional Subscription Agents/Distributors
Current Topics in Peptide & Protein Research   Volumes    Volume 5 
Regulatory peptides involved in the control of intraocular pressure
Iok-Hou Pang
Pages: 171 - 186
Number of pages: 16
Current Topics in Peptide & Protein Research
Volume 5 

Copyright © 2003 Research Trends. All rights reserved


Glaucoma can cause irreversible blindness. An abnormal increase in intraocular pressure (IOP) is a major risk factor for the development of this disease. Currently, the only available treatment method for glaucoma therapy is to lower the IOP. Intraocular pressure is regulated by a delicate balance between the rate of aqueous humor production and its outflow. An upset of this balance, such as a reduction in outflow rate, can generate a destructive ocular hypertension and subsequently lead to retinopathy and optic neuropathy. It is therefore important to understand the involvement of various biological molecules in the regulation of aqueous hydrodynamics.

Biologically active peptides have been studied and demonstrated to affect IOP. This review article summarizes the published literature on the effects of various peptides and related compounds, such as peptide receptor agonist, antagonists, and compounds that affect the synthesis or degradation of particular peptides, on IOP. The endothelins, natriuretic peptides, and components of the renin- angiotensin cascade are among the most studied peptides in this research area.

Buy this Article


Buy this article
Buy this volume
Subscribe to this title
Shopping Cart

Quick Links
Search Products
Browse in Alphabetical Order : Journals
Browse by Subject Classification : Journals

Ordering Information Ordering Information
Downloadable forms Downloadable Forms